ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,744Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 59

$1.49M Total Retail Price of All Prescriptions

Rank: 4 out of 59

537 Patients Receiving at Least One Drug in Part D
41%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

50% of this provider’s 537 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

23% of this provider’s 537 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

6% of this provider’s 3,173 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$153 was the average price of a prescription from this provider, compared to $161 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
OXYCODONE HCL 1,289 366 S2 1 12
PREDNISONE 1,010 445 2 2
CARISOPRODOL 861 147 R 3 11
HYDROCODONE-ACETAMINOPHEN 751 205 S3 4 4
OXYCODONE-ACETAMINOPHEN 638 258 S2 5 13
HYDROXYCHLOROQUINE SULFATE 459 147 6 3
MORPHINE SULFATE ER 400 18 S2 7 15
METHOTREXATE 325 196 8 1
OXYCODONE HCL-ACETAMINOPHEN 292 59 S2 9 26
ENBREL 249 123 10 7
OXYCONTIN 237 113 S2 11 28
ALENDRONATE SODIUM 228 114 12 8
GABAPENTIN 184 69 13 6
LYRICA 161 0 14 14
NAPROXEN 141 33 15 35
TRAZODONE HCL 134 15 16 31
CYMBALTA 114 44 17 18
FORTEO 109 61 18 30
AMITRIPTYLINE HCL 108 45 R 19 46
FENTANYL 106 13 S2 20 29
HUMIRA 101 0 21 17
ACETAMINOPHEN-CODEINE 90 55 S3 22 40
ZOLPIDEM TARTRATE 85 35 23 23
METHOCARBAMOL 78 0 R 24 25
POTASSIUM CHLORIDE 77 30 25 79
LIDODERM 75 0 26 47
ENDOCET 74 15 S2 27 60
ALLOPURINOL 67 39 28 20
TRAMADOL HCL 66 35 29 5
MORPHINE SULFATE 65 16 S2 30 52
RANITIDINE HCL 64 29 31 81
MELOXICAM 64 12 31 10
IBUPROFEN 63 29 33 35
CELEBREX 57 40 34 19
IBANDRONATE SODIUM 54 23 35 62
FUROSEMIDE 53 27 36 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.